We now have an Advocate to Washington D.C. in direct communications with Gen. Gus Perna Chief Operating Officer for Operation Warp Speed.
Dr. Anza Mammen served as the Chief of the Pandemic Warning Team for the U.S. Department of Defense (DoD) at Fort Detrick, MD, where his interagency team monitored for early indicators of global pandemics. He managed vaccine programs for the U.S. Army Medical Research and Materiel Command at Fort Detrick, MD, served as Chief, Department of Virology at the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok, Thailand, and served as an infectious disease officer at the Walter Reed Army Institute of Research (WRAIR) in Silver Spring, MD. Dr. Mammen retired from the U.S. Army with a rank of Colonel and was awarded the Legion of Merit medal for exceptional service. Most recently, Dr. Mammen led clinical development at Vical Inc., a San Diego-based DNA vaccine developer. Dr. Mammen earned his bachelor's degree from Williams College and his medical degree from the Pennsylvania State University College of Medicine; he completed his clinical training at Walter Reed Army Medical Center. He is board-certified in infectious diseases and is a fellow of the Infectious Disease Society of America (IDSA) and of the American College of Physicians (ACP).
Mammen (Anza) Mammen, M.D., FACP, FIDSA joins INOVIO as Senior Vice President, Clinical Development. The former U.S. military vaccine and pandemic expert will oversee the clinical development of INO-4800, INOVIO's DNA vaccine targeting the coronavirus that causes COVID-19. Dr. Mammen will report to Dr. Laurent Humeau, INOVIO's CSO.
A top Army commander has been named the chief operating officer of Operation Warp Speed, the U.S. government’s effort to find a vaccine for COVID-19 by the beginning of next year, President Donald Trump announced.
Gen. Gus Perna, commander of Army Materiel Command, will spearhead the White House initiative. The goal is to produce about 300 million vaccines by January.
Market Data 
Markets 
AI
